Forum LABO Paris 2027

Chemistry CSR Label: the benchmark sector label for responsible and competitive chemistry - France Chimie - AFNOR

Mar 23, 2027 — 04:00 pm - 4:45 PM
Agora

Chemistry CSR Label: the benchmark sector label for responsible and competitive chemistry - France Chimie - AFNOR

Description

This roundtable on the Chemistry CSR Label brings together the label owner, the assessment body and a certified company. The Chemistry CSR Label is the benchmark sector label for companies in the chemical industry that want to structure, strengthen and promote their corporate social responsibility approach, while meeting the expectations of clients and investors. Developed by France Chimie in partnership with AFNOR Certification, it addresses the environmental, social, societal and governance issues specific to the sector. The label assessment is carried out on site by AFNOR Certification, an independent third-party body, which ensures that the essential criteria are met and evaluates the company’s CSR maturity. France Chimie then awards the label based on AFNOR Certification’s recommendation, with one of the label’s four maturity levels. TCN is one of the first companies to receive the Chemistry CSR Label. Long committed to CSR, this SME of 10 employees, specializing in the design, manufacture and marketing of polishing pastes and color preparations, relies on the label to strengthen recognition of its CSR approach.

Suggested sessions

Agora
Mar 23, 2027
10:00 AM11:30 AM
Innovation and scientific valorization

Opening conference - The laboratory in motion: how can we improve efficiency, strengthen reliability, and advance sustainable practices?

Description
Tight budgets, regulatory requirements, automation and artificial intelligence, resource optimization, environmental and climate imperatives... Laboratories must reconcile growing challenges while supporting their teams and preparing for the transformations of the coming years. • How can they innovate while keeping costs under control? • How can they automate while retaining control over operations? • How can they strengthen the reliability of results and reduce their environmental footprint with a constant budget? • How can they develop and retain the necessary skills without increasing pressure on teams? • Though these demands may seem contradictory, they can become drivers of progress. Drawing on feedback from laboratories that have successfully carried out transformations, this opening conference explores the technological, organizational, and human choices that are proving effective. Artificial intelligence, precision or miniaturized instrumentation, new sustainable practices: what concrete benefits can they deliver, what conditions are needed for success, and what impact will they have on professions and roles? Looking at yesterday’s choices to shed light on today’s decisions: which strategic shifts have paid off, which practices can be adapted to other organizations, and which directions should be taken as early as 2027?
Agora
Mar 23, 2027
11:30 AM12:00 PM
Innovation and scientific valorization

Innovation Awards Ceremony

Description
The Forum LABO 2027 Awards celebrate and recognize projects, laboratories, teams, and individuals who stand out for their scientific or technical excellence, a major innovation, or a significant impact on their region, their sector, or the scientific community. These awards also encourage collaboration, equality, and diversity in the scientific world.
Salle Marie Curie
Mar 23, 2027
2:00 PM3:00 PM
Biotechnology, science and healthcare of tomorrow

Inside the Joint Laboratory Service

Description
The Joint Laboratory Service stands out for its unique way of operating, making it a network of official laboratories at the heart of government action. It works for several government bodies on an extremely wide range of issues, from toys to narcotics, from verifying the accuracy of claims to food safety, as well as checking geographical origins and the naturalness of ingredients. Its scope of expertise covers 29 scientific fields and includes handling samples collected by inspection authorities, both for high-volume routine analyses (for example, pesticide residues in imported fruit and vegetables) and for in-depth expert investigations on specific topics (for example, the structural elucidation of new psychoactive substances using NMR and high-resolution mass spectrometry).
Le Service Commun des Laboratoire
Espace Librairie
Mar 23, 2027
3:00 PM3:45 PM
Book signing

Book signing - Sandrine Mirza - Women in the history of science

Description
Meet Sandrine Mirza at a book signing session for her book Women in the History of Science. A special opportunity to talk with the author, discover her perspective on the role of women in the history of science, and leave with a signed copy.
Salle Marie Curie
Mar 23, 2027
3:00 PM3:45 PM
Biotechnology, science and healthcare of tomorrow

Hemarina – a human, scientific and entrepreneurial adventure

Description
Oxygen is essential to life, and hemoglobin is the molecule responsible for transporting almost all of the oxygen present in the circulatory system of most living species. During this conference, our speaker will retrace the story of the discovery of a natural extracellular hemoglobin called M101, derived from a marine organism, Arenicola marina, and its applications in medicine. This non-allergenic and non-immunogenic molecule carries 40 times more oxygen than HbA and is 250 times smaller than a red blood cell. Its intrinsic properties make it a broad-spectrum therapeutic tool for ensuring effective tissue oxygenation in various clinical situations where ischemia and/or anemia are the triggering factors. The applications of the M101 molecule are almost limitless, as it can potentially act wherever oxygen is needed: in composite tissue transplants (organs, skin, face, limbs, etc.), during vaso-occlusive crises in patients with sickle cell disease, in cases of myocardial infarction, cerebral ischemia, in oncology (radiotherapy, CAR-T cells for hypoxic tumors), in the development of oxygenating dressings for hypoxic wounds, and in the treatment of periodontal diseases. This presentation will provide an overview of the development of the M101 molecule and its various therapeutic applications.
HEMARINA
Agora
Mar 23, 2027
3:00 PM3:45 PM
Biotechnology, science and healthcare of tomorrow

SFSTP +POLEPHARMA

Description
Information coming soon